Inside the tactical tug of war over the controversial Alzheimer’s drugInside the tactical tug of war over the controversial Alzheimer’s drugInside the tactical tug of war over the controversial Alzheimer’s drug

Inside the tactical tug of war over the controversial Alzheimer’s drug

An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.

from Section Page News - Modern Healthcare https://ift.tt/ZtmQSay